(RTTNews) - Moberg Pharma AB (MOB.ST) announced the publication of new analyses in the Journal of Fungi, 2026 showing that Terbinafine maintained strong antifungal activity against dermatophytes, the fungi responsible for most nail fungus infections, while MOB-015 achieved fungal
Key PointsPresident Trump recently doubled down on his commitment to pay a $5,000 Trump Dividend to adult U.S. citizens if Republicans retain the U.S. Senate and House on Election Day.
Key PointsChevron has a 3.5% yield, and the integrated energy giant is in the midst of a cost-cutting plan that could increase cash flow by 10% annually between now and 2030.
(RTTNews) - Qualcomm Inc. (QCOM) said Monday it has signed a multi-year patent license agreement with Huawei covering cross licenses to the companies' patent portfolios across 5G, compute, artificial intelligence and networking technologies.
(RTTNews) - e.l.f. Beauty, Inc (ELF) announced on Monday that its unit e.l.f brands is expanding into fragrance and body care with the launch of e.l.f. POP, a collection built around signature scents inspired by destinations.
(RTTNews) - Air Liquide (AI.PA) unveiled BEYOND, its strategic plan through 2030. The company targets: a compound annual growth rate of 10% with +/-2% over the period in recurring net earnings per share; a recurring ROCE above 11% in 2030, and pursuing a 33% reduction in CO2 emis
(RTTNews) - Skanska AB (SKA-B.ST), a Swedish construction and engineering company, Monday announced that it has amended a contract with an existing client of an education project in West U.S. for $78 million.
(RTTNews) - Foghorn Therapeutics Inc. (FHTX), a biotechnology company developing medicines targeting genetically determined dependencies in the chromatin regulatory system, said it will not advance FHD-909 program after reviewing data from its Phase 1 dose-escalation trial.